Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Griesel R, Maartens G, Chirehwa M, Sokhela S, et al. Clin Infect Dis 2022 Jan 31. pii: 6517845. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Griesel R, Maartens G, Chirehwa M, Sokhela S, et al. Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clin Infect Dis 2022 Jan 31. pii: 6517845. doi: 10.1093.
PMID: 35099526